Codelivery of salinomycin and chloroquine by liposomes enables synergistic antitumor activity in vitro.
about
Nanomedicine strategies for sustained, controlled and targeted treatment of cancer stem cells.Polymer-lipid hybrid anti-HER2 nanoparticles for targeted salinomycin delivery to HER2-positive breast cancer stem cells and cancer cells.Cationic liposomes induce cell necrosis through lysosomal dysfunction and late-stage autophagic flux inhibition.The combination therapy of salinomycin and gefitinib using poly(d,l-lactic-co-glycolic acid)-poly(ethylene glycol) nanoparticles for targeting both lung cancer stem cells and cancer cells.Self-targeted salinomycin-loaded DSPE-PEG-methotrexate nanomicelles for targeting both head and neck squamous cell carcinoma cancer cells and cancer stem cells.Epidermal growth factor receptor aptamer-conjugated polymer-lipid hybrid nanoparticles enhance salinomycin delivery to osteosarcoma and cancer stem cells.Salinomycin-loaded lipid-polymer nanoparticles with anti-CD20 aptamers selectively suppress human CD20+ melanoma stem cells.Salinomycin, as an autophagy modulator-- a new avenue to anticancer: a review.Therapeutic PEG-ceramide nanomicelles synergize with salinomycin to target both liver cancer cells and cancer stem cells.The enhanced delivery of salinomycin to CD133+ ovarian cancer stem cells through CD133 antibody conjugation with poly(lactic-co-glycolic acid)-poly(ethylene glycol) nanoparticles.
P2860
Q38794563-993A4A7A-1E6C-4C00-BA03-1524E8FAE2DEQ42731720-9443B35E-B592-4D02-BA82-F50D464D0FE3Q45861640-642CEFEC-D9AA-4A1A-A0EC-6DF6666AD0E5Q47118493-A26CA5E9-2478-49B4-A7C6-7BDB9F184E01Q48868934-4F7A34BC-36B5-4683-9215-707ACFD8F08AQ49335412-5994D7FC-D5CA-4032-BD69-F54910B78369Q49501113-C54A64DC-C9CE-4036-8707-6FC3FCB35B2AQ50057844-1EB84A71-0BE2-403E-B96C-FCCADA1EE354Q52876806-E2C972BD-BCBA-48D5-9441-90103FDA7E05Q55430613-06FA2754-661B-4057-AA98-7157D972ADE4
P2860
Codelivery of salinomycin and chloroquine by liposomes enables synergistic antitumor activity in vitro.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Codelivery of salinomycin and ...... c antitumor activity in vitro.
@en
type
label
Codelivery of salinomycin and ...... c antitumor activity in vitro.
@en
prefLabel
Codelivery of salinomycin and ...... c antitumor activity in vitro.
@en
P2093
P2860
P356
P1433
P1476
Codelivery of salinomycin and ...... c antitumor activity in vitro.
@en
P2093
Fangyuan Xie
Guoqing Zhang
Junjie Liu
Kaixuan Yang
Siyue Zhang
P2860
P304
P356
10.2217/NNM-2016-0125
P577
2016-07-08T00:00:00Z